https://www.pharmanow.live/latest-news/ab-science-revises-clinical-trial-timelines-for-cause-gcp-inspection 2026-09-29T18:44:13+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Ab Science Revises Trial Timelines After Three Gcp Inspections Ab Science https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ab-science-cause-gcp-inspection-clinical-trial-timelines-202620260929184005.webp https://www.pharmanow.live/latest-news/novo-nordisk-hengrui-pharma-license-hrs-1596-oral-glp1-gip-agonist 2026-09-29T18:32:53+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Novo Nordisk Signs $2.6B Deal With Hengrui For Oral GLP-1 Novo Nordisk https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novo-nordisk-hengrui-pharma-hrs-1596-oral-glp1-gip-agonist20260929183200.webp https://www.pharmanow.live/latest-news/teva-fda-approval-degevma-denosumab-biosimilar-xgeva 2026-09-29T18:25:52+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 Teva Wins FDA Nod For DEGEVMA, Completing Denosumab Portfolio Teva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/teva-fda-approval-degevma-denosumab-biosimilar-xgeva20260929182504.webp https://www.pharmanow.live/latest-news/boothwyn-pharmacy-fda-warning-letter-sterility-potency-failures-2026 2026-09-29T18:21:52+05:30 Pharma Now en 2026-09-29T00:00:00+05:30 FDA Warns Boothwyn Pharmacy Over Sterility, Potency Issues FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/boothwyn-pharmacy-fda-warning-letter-sterility-potency-failures-202620260929182105.webp https://www.pharmanow.live/latest-news/oryzon-ema-cta-vafidemstat-hope-2-phelan-mcdermid-syndrome 2026-09-29T10:41:54+05:30 Pharma Now en 2026-09-28T00:00:00+05:30 Oryzon Gains Ema Cta For Vafidemstat Phase Ii Pms Study Oryzon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/oryzon-genomics-vafidemstat-hope-2-phelan-mcdermid-syndrome-202620260929103927.webp https://www.pharmanow.live/latest-news/inventiva-nativ3-phase-3-topline-results-lanifibranor-mash-2026 2026-09-29T10:36:25+05:30 Pharma Now en 2026-09-28T00:00:00+05:30 Inventiva Awaits Phase 3 Nativ3 Data For Lanifibranor Inventiva https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/inventiva-nativ3-phase-3-lanifibranor-mash-results-202620260929103452.webp